Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Sep 21 EFFECT Notice of effectiveness
- 28 Sep 21 424B3 Prospectus supplement
-
10 Sep 21 S-4 Registration of securities issued in business combination transactions
VTRS similar filings
- 10 Sep 21 Registration of securities issued in business combination transactions
- 6 Feb 20 Registration of securities issued in business combination transactions (amended)
- 21 Jan 20 Registration of securities issued in business combination transactions (amended)
- 13 Dec 19 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 15.1
KPMG LLP 345 Park Avenue New York, NY 10154 |
September 10, 2021
Re: Registration Statement on Form S-4 of Viatris Inc.
With respect to the subject registration statement, we acknowledge our awareness of the use therein of our report dated December 23, 2020 related to our review of interim financial information of Upjohn (formerly a business unit of Pfizer Inc.).
Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.
/s/ KPMG LLP |
New York, New York |